Vera Therapeutics Stock Market Value
| VERA Stock | USD 27.99 0.33 1.19% |
| Symbol | Vera |
Vera Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vera Therapeutics. If investors know Vera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vera Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vera Therapeutics is measured differently than its book value, which is the value of Vera that is recorded on the company's balance sheet. Investors also form their own opinion of Vera Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Vera Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vera Therapeutics' market value can be influenced by many factors that don't directly affect Vera Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vera Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vera Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vera Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vera Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vera Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vera Therapeutics.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in Vera Therapeutics on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding Vera Therapeutics or generate 0.0% return on investment in Vera Therapeutics over 90 days. Vera Therapeutics is related to or competes with Third Harmonic, Cullinan Oncology, Edgewise Therapeutics, Rallybio Corp, Monte Rosa, Travere Therapeutics, and Cytokinetics. Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments fo... More
Vera Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vera Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vera Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 25.08 | |||
| Value At Risk | (5.81) | |||
| Potential Upside | 4.76 |
Vera Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vera Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vera Therapeutics' standard deviation. In reality, there are many statistical measures that can use Vera Therapeutics historical prices to predict the future Vera Therapeutics' volatility.| Risk Adjusted Performance | (0.16) | |||
| Jensen Alpha | (0.61) | |||
| Total Risk Alpha | (0.12) | |||
| Treynor Ratio | (0.70) |
Vera Therapeutics Backtested Returns
Vera Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.17, which indicates the firm had a -0.17 % return per unit of risk over the last 3 months. Vera Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vera Therapeutics' Coefficient Of Variation of (504.25), variance of 14.62, and Risk Adjusted Performance of (0.16) to confirm the risk estimate we provide. The entity has a beta of 1.1, which indicates a somewhat significant risk relative to the market. Vera Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Vera Therapeutics is expected to follow. At this point, Vera Therapeutics has a negative expected return of -0.67%. Please make sure to validate Vera Therapeutics' maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and day typical price , to decide if Vera Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.71 |
Good predictability
Vera Therapeutics has good predictability. Overlapping area represents the amount of predictability between Vera Therapeutics time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vera Therapeutics price movement. The serial correlation of 0.71 indicates that around 71.0% of current Vera Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.71 | |
| Spearman Rank Test | 0.56 | |
| Residual Average | 0.0 | |
| Price Variance | 16.1 |
Vera Therapeutics lagged returns against current returns
Autocorrelation, which is Vera Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Vera Therapeutics' stock expected returns. We can calculate the autocorrelation of Vera Therapeutics returns to help us make a trade decision. For example, suppose you find that Vera Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Vera Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Vera Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Vera Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Vera Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Vera Therapeutics Lagged Returns
When evaluating Vera Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Vera Therapeutics stock have on its future price. Vera Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Vera Therapeutics autocorrelation shows the relationship between Vera Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Vera Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vera Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vera Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vera Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vera Therapeutics Stock:Check out Vera Therapeutics Correlation, Vera Therapeutics Volatility and Vera Therapeutics Alpha and Beta module to complement your research on Vera Therapeutics. For information on how to trade Vera Stock refer to our How to Trade Vera Stock guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Vera Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.